Indivior Pharmaceuticals annual capital expenditures (capex)
2021
2022
2023
2024
2025
Indivior Pharmaceuticals Capital Expenditures (CapEx) Growth & History (INDV)
Indivior Pharmaceuticals's capital expenditures (capex) was $66.0M for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $66.0M | $37.0M | +127.59% |
| 2024 | 2024-12-31 | $29.0M | $21.0M | +262.50% |
| 2023 | 2023-12-31 | $8.0M | $3.0M | +60.00% |
| 2022 | 2022-12-31 | $5.0M | $1.0M | +25.00% |
| 2021 | 2021-12-31 | $4.0M | — | — |
Indivior Pharmaceuticals quarterly capital expenditures (capex)
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.0M | −$10.0M | −58.82% |
| Q1 2026 | 2026-03-31 | $20.0M | $15.0M | +300.00% |
| Q4 2025 | 2025-12-31 | $24.0M | $8.0M | +50.00% |
| Q3 2025 | 2025-09-30 | $20.0M | $13.0M | +185.71% |
| Q2 2025 | 2025-06-30 | $17.0M | $13.0M | +325.00% |
| Q1 2025 | 2025-03-31 | $5.0M | $3.0M | +150.00% |
| Q4 2024 | 2024-12-31 | $16.0M | — | — |
| Q3 2024 | 2024-09-30 | $7.0M | — | — |
| Q2 2024 | 2024-06-30 | $4.0M | — | — |
| Q1 2024 | 2024-03-31 | $2.0M | — | — |
Indivior Pharmaceuticals capital expenditures (capex) trends
Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's capital expenditures (capex) increased from $4.0M to $66.0M, a change of $62.0M. The latest reported quarter, Q2 2026, shows $7.0M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals source filings ↗